(MENAFN- GlobeNewsWire - Nasdaq) The European Syringe Infusion Pump Market, valued at USD 465.1M in 2024, is projected to reach USD 729.5M by 2030, growing at a 7.90% CAGR. This growth is driven by rising preterm births, chronic diseases, and advanced technology adoption. Leading segments include pediatrics/neonatology and hospitals. Germany holds the largest market share, with rapid growth expected in home care. The report offers detailed market analysis, future trends, and actionable recommendations for strategic decision-making.

Dublin, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The "Europe Syringe Infusion Pump Market Size, Share & Trends Analysis Report by Disease Indication (Chemotherapy, Gastroenterology, Hematology), End-use, Country with Growth Forecasts, 2025-2030" has been added to ResearchAndMarkets.com's offering.
The European Syringe Infusion Pump Market is projected to grow from USD 465.1 million in 2024 to USD 729.5 million by 2030, at a CAGR of 7.9%. This growth is fueled by the increasing incidence of preterm births, the rising prevalence of chronic diseases, and the drive towards advanced technology in healthcare equipment. Additionally, the surge in cancer cases and diabetes diagnoses, along with the rise in intensive care unit admissions, contribute significantly to the market's expansion.

The launch of innovative products featuring real-time monitoring capabilities is set to enhance product adoption in hospitals and healthcare facilities. Advancements propelled by research-based developments, regulatory mandates for device safety and quality, and the rising demand for controlled medication delivery and precision dosing in critical care applications present substantial growth opportunities.

Europe Syringe Infusion Pump Market Report Highlights

• Pediatrics/Neonatology Segment: Led the market with a 26.2% revenue share in 2024, reflecting the role of syringe infusion pumps in controlled drug delivery for newborns.
• Chemotherapy Segment: Expected to witness the fastest CAGR through 2030, driven by increasing chronic disease incidences and the merging of palliative care with cancer treatments.
• Hospitals Segment: Accounted for the largest market revenue share in 2024, highlighting the need for precision dosing and controlled drug delivery in various treatments.
• Home Care Segment: Projected to grow at the fastest CAGR from 2025 to 2030.
• Germany: Dominated the market with the largest revenue share in 2024 due to the presence of manufacturers and extensive applications in intensive care, chemotherapy, and pain management.

This report addresses:

• Market insights for informed decision-making
• Market estimates and forecasts from 2018 to 2030
• Identifying growth opportunities and trends
• Segment and regional revenue forecasts
• Analysis of competition strategies and market share
• Innovative product listings to keep in touch with market advancements

Why Should You Buy This Report?

• Comprehensive Market Analysis: Gain insights into key market regions and segments.
• Competitive Landscape: Understand the market presence of leading players.
• Future Trends: Discover trends and drivers shaping the market's future.
• Actionable Recommendations: Leverage insights to explore new revenue streams and inform strategic business decisions.

Companies Featured
The major companies featured in this Europe Syringe Infusion Pump market report include:

• B. Braun SE
• Baxter
• BD
• Fresenius Kabi AG
• Micrel Medical Devices SA
• CODAN Companies
• Arcomed
• ICU Medical, Inc. (Smiths Medical)
• Terumo Corporation
• Moog Inc.

Key Attributes:

Report Attribute	Details
No. of Pages	80
Forecast Period	2024 - 2030
Estimated Market Value (USD) in 2024	$465.1 Million
Forecasted Market Value (USD) by 2030	$729.5 Million
Compound Annual Growth Rate	7.9%
Regions Covered	Europe

Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease indication outlook
2.2.2. End use outlook
2.2.3. Country outlook
2.3. Competitive Insights
Chapter 3. Europe Syringe Infusion Pumps Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.3. Europe Syringe Infusion Pumps Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
Chapter 4. Europe Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis
4.1. Disease Indication Segment Dashboard
4.2. Europe Syringe Infusion Pumps Market: Disease Indication Movement Analysis
4.3. Europe Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
4.4. Chemotherapy
4.5. Diabetes
4.6. Gastroenterology
4.7. Analgesia/Pain Management
4.8. Pediatrics/Neonatology
4.9. Hematology
4.10. Others
Chapter 5. Europe Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis
5.1. End Use Segment Dashboard
5.2. Europe Syringe Infusion Pumps Market: End Use Movement Analysis
5.3. Europe Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.5. Homecare
5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)
Chapter 6. Europe Syringe Infusion Pumps Market: Country Estimates & Trend Analysis
6.1. Country Market Dashboard
6.2. Country Market Share Analysis, 2024 & 2030
6.3. Europe Syringe Infusion Pumps Market, By Country: Key Takeaways
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape

• B. Braun SE
• Baxter
• BD
• Fresenius Kabi AG
• Micrel Medical Devices SA
• CODAN Companies
• Arcomed
• ICU Medical, Inc. (Smiths Medical)
• Terumo Corporation
• Moog Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• European Syringe Infusion Pump Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN04082025004107003653ID1109880570